Furthermore, it was shown that one mechanism underlying the synergism displayed by the combination between minute doses of murine NGR–TNF and doxorubicin was related to vascular barrier alteration and thus increased the uptake of this chemotherapeutic agent in tumours (Curnis et al, 2002). Here, RTN4R is linked to neoplasm.